Mónica Martín de Bustamante

Mónica Martín de Bustamante

Senior Partner &
Head of Advisory and Evidence, Value, Access and Pricing (EVAP)

Ms. Martin de Bustamante’s career has focused on pharmaceutical global pricing and market access issues for biopharmaceutical and pharmaceutical products. Her time has been apportioned between the mature and emerging markets, with deep expertise in the USA, EU5, CAN, and JPN. Ms. Martin de Bustamante has worked across the major therapeutic areas (oncology, cardiovascular, neurology, metabolic, autoimmune, gastrointestinal, respiratory, etc.) collaborating on products from their early development, through launch, and following through their lifecycle.

Much of Ms. Martin de Bustamante’s work to date has centered around understanding the barriers to access and reimbursement challenges posed by evolving healthcare systems and evidence requirements. She has extensive global experience in early and late-stage pricing, market access strategies, value proposition development, lifecycle management, generic or biosimilar erosion counterstrategies, and patient support programs.

Ms. Martin de Bustamante has worked within the life sciences consulting industry for over 10 years. She holds a Bachelor’s in Biomedical Engineering and a Bachelors in Romance Languages & Engineering Sciences from Dartmouth College and speaks both Spanish and English at native level fluency.

If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.